7Baggers

Treace Medical Concepts Inc
(NASDAQ:TMCI) 

TMCI stock logo

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics.

Founded: 2014
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Manufacturing
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                        
      revenue
    		47,198,000 50,214,000 47,387,000 52,570,000 68,708,000 45,086,000 44,455,000 51,108,000 62,212,000 40,758,000 41,953,000 42,195,000 49,769,000 33,055,000 29,967,000 29,047,000 33,439,000 21,619,000 20,654,000 18,707,000 
      yoy
    		-31.31% 11.37% 6.60% 2.86% 10.44% 10.62% 5.96% 21.12% 25.00% 23.30% 40.00% 45.26% 48.84% 52.90% 45.09% 55.27%     
      qoq
    		-6.01% 5.97% -9.86% -23.49% 52.39% 1.42% -13.02% -17.85% 52.64% -2.85% -0.57% -15.22% 50.56% 10.30% 3.17% -13.13% 54.67% 4.67% 10.41%  
      cost of goods sold
    		9,791,000 10,508,000 9,635,000 10,677,000 13,231,000 8,954,000 8,781,000 10,127,000 11,469,000 7,998,000 7,675,000 8,039,000 9,742,000 6,624,000 5,651,000 5,506,000 6,307,000 4,248,000 3,944,000 3,327,000 
      gross profit
    		37,407,000 39,706,000 37,752,000 41,893,000 55,477,000 36,132,000 35,674,000 40,981,000 50,743,000 32,760,000 34,278,000 34,156,000 40,027,000 26,431,000 24,316,000 23,541,000 27,132,000 17,371,000 16,710,000 15,380,000 
      yoy
    		-32.57% 9.89% 5.82% 2.23% 9.33% 10.29% 4.07% 19.98% 26.77% 23.95% 40.97% 45.09% 47.53% 52.16% 45.52% 53.06%     
      qoq
    		-5.79% 5.18% -9.88% -24.49% 53.54% 1.28% -12.95% -19.24% 54.89% -4.43% 0.36% -14.67% 51.44% 8.70% 3.29% -13.24% 56.19% 3.96% 8.65%  
      gross margin %
    		79.26% 79.07% 79.67% 79.69% 80.74% 80.14% 80.25% 80.19% 81.56% 80.38% 81.71% 80.95% 80.43% 79.96% 81.14% 81.04% 81.14% 80.35% 80.90% 82.22% 
      operating expenses
    		                    
      sales and marketing
    		33,775,000 34,421,000 33,084,000 36,122,000 36,859,000 32,775,000 37,681,000 40,328,000 39,924,000 33,542,000 33,773,000 33,655,000 29,369,000 25,034,000 26,250,000 21,923,000 22,325,000 15,984,000 14,010,000 12,148,000 
      research and development
    		4,622,000 4,680,000 5,498,000 5,562,000 5,210,000 4,963,000 5,157,000 5,259,000 4,152,000 4,350,000 3,526,000 3,412,000 3,749,000 3,799,000 2,984,000 3,052,000 3,377,000 2,537,000 2,422,000 1,868,000 
      general and administrative
    		16,177,000 16,281,000 16,144,000 15,791,000 13,612,000 13,528,000 14,218,000 14,362,000 13,449,000 12,686,000 10,031,000 10,865,000 10,406,000 8,916,000 7,015,000 6,662,000 7,027,000 4,310,000 4,329,000 2,766,000 
      total operating expenses
    		54,574,000 55,382,000 54,726,000 57,475,000 55,681,000 51,266,000 57,056,000 59,949,000 57,525,000 50,578,000 47,330,000 47,932,000 43,524,000 37,749,000 36,249,000 31,637,000 32,729,000 22,831,000 20,761,000 16,782,000 
      income from operations
    		-17,167,000 -15,676,000 -16,974,000 -15,582,000 -204,000 -15,134,000 -21,382,000 -18,968,000 -6,782,000 -17,818,000 -13,052,000 -13,776,000 -3,497,000 -11,318,000 -11,933,000 -8,096,000 -5,597,000 -5,460,000 -4,051,000 -1,402,000 
      yoy
    		8315.20% 3.58% -20.62% -17.85% -96.99% -15.06% 63.82% 37.69% 93.94% 57.43% 9.38% 70.16% -37.52% 107.29% 194.57% 477.46%     
      qoq
    		9.51% -7.65% 8.93% 7538.24% -98.65% -29.22% 12.73% 179.68% -61.94% 36.52% -5.26% 293.94% -69.10% -5.15% 47.39% 44.65% 2.51% 34.78% 188.94%  
      operating margin %
    		-36.37% -31.22% -35.82% -29.64% -0.30% -33.57% -48.10% -37.11% -10.90% -43.72% -31.11% -32.65% -7.03% -34.24% -39.82% -27.87% -16.74% -25.26% -19.61% -7.49% 
      interest income
    		501,000 634,000 775,000 841,000 899,000 1,067,000 1,376,000 1,535,000 1,709,000 1,570,000 1,968,000 1,479,000         
      interest expense
    		-1,570,000 -1,338,000 -1,321,000 -1,311,000 -1,314,000 -1,313,000 -1,312,000 -1,317,000 -1,304,000 -1,296,000 -1,282,000 -1,285,000 -1,311,000 -1,190,000 -946,000 -951,000 -1,028,000 -963,000 -1,038,000 -1,031,000 
      other income
    		275,000 92,000 122,000 130,000 118,000 20,000 112,000 74,000 96,000 23,000 95,000 128,000        -1,030,000 
      other non-operating income
    		-794,000 -612,000 -424,000 -340,000 -297,000 -226,000 176,000 292,000 501,000 297,000 781,000 322,000         
      net income
    		-17,961,000 -16,288,000 -17,398,000 -15,922,000 -501,000 -15,360,000 -21,206,000 -18,676,000 -6,281,000 -17,521,000 -12,271,000 -13,454,000         
      yoy
    		3485.03% 6.04% -17.96% -14.75% -92.02% -12.33% 72.81% 38.81%             
      qoq
    		10.27% -6.38% 9.27% 3078.04% -96.74% -27.57% 13.55% 197.34% -64.15% 42.78% -8.79%          
      net income margin %
    		-38.05% -32.44% -36.71% -30.29% -0.73% -34.07% -47.70% -36.54% -10.10% -42.99% -29.25% -31.89% 0% 0% 0% 0% 0% 0% 0% 0% 
      other comprehensive income
    		                    
      unrealized gain on marketable securities
    		-98,000 33,000 -7,000 -40,000 -94,000 217,000 -95,000 -94,000 311,000 71,000           
      comprehensive loss
    		-18,059,000 -16,255,000 -17,405,000 -15,962,000 -595,000 -15,143,000 -21,301,000 -18,770,000 -5,970,000 -17,450,000 -12,434,000 -13,483,000         
      net income per share
    		-0.28 -0.26 -0.28 -0.25 -0.01 -0.25 -0.34 -0.3 -0.1 -0.28 -0.2 -0.23 -0.07 -0.22 -0.31 -0.16 -0.13 -0.12 -0.1 -0.07 
      weighted-average shares used for eps calculation
    		64,592,681 63,515,372 63,006,891 62,661,447 62,112,037 62,229,463 62,081,494 61,792,788 60,852,153 61,562,494 61,382,514 58,723,760 55,276,834 55,429,211 55,308,273 54,827,665 48,415,679 52,766,150 49,187,285 37,854,687 
      debt extinguishment loss
    		              -4,483,000      
      other comprehensive income:
    		                    
      unrealized loss on marketable securities
    		          -163,000 -29,000         
      interest and other income
    		            396,000 375,000 128,000 11,000 6,000 5,000 6,000 1,000 
      other expense
    		            -915,000 -815,000 -5,301,000 -940,000 -1,022,000 -958,000 -1,032,000  
      net loss and comprehensive loss
    		            -9,600,750 -12,133,000 -17,234,000 -9,036,000 -6,619,000 -6,418,000 -5,083,000 -2,432,000 
      convertible preferred stock cumulative and undeclared dividends
    		                  -39,000 -158,000 
      net loss attributable to common stockholders
    		            -4,412,000 -12,133,000 -17,234,000 -9,036,000 -6,619,000 -6,418,000 -5,122,000 -2,590,000 
      operating expenses:
    		                    
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                          
        assets
      		                    
        current assets
      		                    
        cash and cash equivalents
      		9,544,000 7,686,000 8,052,000 13,372,000 11,350,000 12,110,000 18,181,000 9,334,000 12,982,000 7,278,000 12,035,000 29,613,000 19,473,000 88,546,000 101,533,000 98,483,000 105,833,000 109,459,000 119,621,000 16,218,000 
        marketable securities, short-term
      		42,310,000 49,730,000 61,237,000 62,717,000 64,327,000 70,689,000 76,865,000 100,672,000 110,216,000 114,885,000 127,444,000 141,049,000 61,779,000        
        accounts receivable
      		30,358,000 32,959,000 30,333,000 31,110,000 40,803,000 24,177,000 25,559,000 30,083,000 38,063,000 24,996,000 27,232,000 25,365,000 29,196,000 18,548,000 16,501,000 15,995,000 18,568,000 11,795,000 10,047,000 10,793,000 
        inventories
      		36,366,000 41,424,000 42,397,000 37,940,000 39,255,000 43,611,000 41,279,000 35,860,000 29,245,000 29,312,000 26,101,000 22,519,000 19,330,000 16,794,000 13,168,000 11,112,000 10,561,000 10,351,000 7,643,000 7,370,000 
        prepaid expenses and other current assets
      		4,893,000 6,198,000 5,583,000 4,298,000 5,667,000 7,015,000 9,668,000 11,448,000 7,853,000 10,671,000 5,284,000 4,587,000 3,624,000 4,014,000 3,995,000 1,723,000 3,010,000 3,760,000 3,512,000 2,072,000 
        total current assets
      		123,471,000 137,997,000 147,602,000 149,437,000 161,402,000 157,602,000 171,552,000 187,397,000 198,359,000 187,142,000 198,096,000 223,133,000 133,402,000 127,902,000 135,197,000 127,313,000 137,972,000 135,365,000 140,823,000 36,453,000 
        property and equipment
      		32,063,000 29,970,000 29,708,000 27,129,000 25,953,000 25,168,000 24,245,000 24,517,000 22,298,000 21,536,000 19,435,000 15,915,000 15,338,000 14,148,000 8,741,000 3,996,000 2,849,000 2,225,000 1,475,000 929,000 
        intangible assets, net of accumulated amortization of 2,613 and 2,375 as of march 31, 2026 and december 31, 2025, respectively
      		6,887,000                    
        goodwill
      		12,815,000 12,815,000 12,815,000 12,815,000 12,815,000 12,815,000 12,815,000 12,815,000 12,815,000 12,815,000 12,815,000          
        operating lease right-of-use assets
      		7,371,000 7,833,000 8,042,000 8,241,000 8,442,000 8,569,000 8,775,000 9,064,000 9,264,000 9,459,000 9,651,000 9,907,000 10,138,000 14,247,000 14,650,000 15,069,000     
        other non-current assets, net of allowance for credit losses of 52 and 69 as of march 31, 2026 and december 31, 2025, respectively
      		1,495,000                    
        total assets
      		184,102,000 196,591,000 206,443,000 205,846,000 217,094,000 212,924,000 226,083,000 242,726,000 251,907,000 240,360,000 249,643,000 249,170,000 159,024,000 156,443,000 158,722,000 146,512,000 140,821,000 137,590,000 142,298,000 37,382,000 
        liabilities and stockholders’ equity
      		                    
        current liabilities
      		                    
        accounts payable
      		13,537,000 16,103,000 19,959,000 13,223,000 10,522,000 18,649,000 18,073,000 21,149,000 11,835,000 8,680,000 8,146,000 5,076,000 8,668,000 7,881,000 3,099,000 3,448,000 4,056,000 2,442,000 2,921,000 1,269,000 
        accrued liabilities
      		5,978,000 7,315,000 6,192,000 6,008,000 7,197,000 8,098,000 13,730,000 15,155,000 10,458,000 8,936,000 7,072,000 7,971,000 6,216,000 5,189,000 4,809,000 3,552,000 4,518,000 2,824,000 1,957,000 2,821,000 
        accrued commissions
      		6,755,000 6,215,000 5,328,000 6,529,000 10,121,000 5,347,000 5,931,000 5,527,000 10,759,000 5,278,000 5,661,000 5,891,000 7,356,000 4,131,000 4,308,000 3,882,000 5,181,000 3,021,000 2,553,000 2,716,000 
        accrued compensation
      		5,621,000 7,172,000 7,064,000 5,190,000 6,575,000 5,598,000 6,192,000 4,196,000 7,549,000 5,070,000 5,368,000 3,300,000 7,666,000 5,049,000 4,038,000 4,060,000 4,455,000 2,436,000 2,434,000 1,782,000 
        other liabilities
      		2,600,000 4,103,000 3,357,000 2,230,000 510,000 571,000 520,000 1,022,000 4,432,000 5,190,000 3,775,000          
        total current liabilities
      		34,491,000 40,908,000 41,900,000 33,180,000 34,925,000 38,263,000 44,446,000 47,049,000 45,033,000 33,154,000 30,022,000 23,296,000 30,245,000 22,580,000 16,637,000 15,377,000 18,210,000 10,723,000 9,865,000 8,588,000 
        long-term debt
      		55,820,000 53,529,000 53,454,000 53,380,000 53,306,000 53,231,000 53,157,000 53,083,000 53,008,000 52,934,000 52,859,000 52,785,000 52,711,000 52,636,000 52,562,000 29,410,000 29,365,000 29,321,000 29,277,000 29,233,000 
        operating lease liabilities, net of current portion
      		13,551,000 12,930,000 13,437,000 13,908,000 15,934,000 16,487,000 16,302,000 16,166,000 15,891,000 16,375,000 16,766,000 15,447,000 15,539,000 19,026,000 17,811,000 14,824,000     
        other long-term liabilities
      		3,049,000 37,000 37,000 37,000 37,000 37,000 37,000 37,000 37,000 37,000 37,000 25,000         
        total liabilities
      		106,911,000 107,404,000 108,828,000 100,505,000 104,202,000 108,018,000 113,942,000 116,335,000 113,969,000 102,500,000 99,684,000 91,553,000 98,495,000 94,242,000 87,010,000 59,694,000 47,748,000 40,217,000 39,387,000 38,066,000 
        commitments and contingencies
      		                    
        stockholders’ equity
      		                    
        preferred stock, 0.001 par value...
      		                    
        common stock, 0.001 par value...
      		65,000 64,000 63,000 63,000 62,000 62,000 62,000 62,000 62,000 62,000 62,000 61,000 55,000 46,000 46,000 46,000 45,000 45,000 45,000  
        additional paid-in capital
      		345,495,000 329,746,000 321,508,000 311,815,000 303,004,000 294,392,000 286,484,000 279,433,000 271,973,000 265,912,000 260,561,000 255,786,000 145,221,000 142,463,000 139,841,000 137,713,000 134,933,000 132,614,000 131,734,000 15,136,000 
        accumulated deficit
      		-266,953,000 -239,598,000 -223,310,000 -205,912,000 -189,990,000 -189,489,000 -174,129,000 -152,923,000 -134,247,000 -127,966,000 -110,445,000 -98,174,000 -84,720,000 -80,308,000 -68,175,000 -50,941,000 -41,905,000 -35,286,000 -28,868,000 -23,785,000 
        accumulated other comprehensive income
      		-26,000 83,000 50,000 57,000 97,000 191,000 -26,000 69,000 163,000 -148,000 -219,000 -56,000 -27,000        
        treasury stock
      		-1,390,000 -1,108,000 -696,000 -682,000 -281,000 -250,000 -250,000 -250,000 -13,000            
        total stockholders’ equity
      		77,191,000 89,187,000 97,615,000 105,341,000 112,892,000 104,906,000 112,141,000 126,391,000 137,938,000 137,860,000 149,959,000 157,617,000 60,529,000 62,201,000 71,712,000 86,818,000 93,073,000 97,373,000 102,911,000  
        total liabilities and stockholders’ equity
      		184,102,000 196,591,000 206,443,000 205,846,000 217,094,000 212,924,000 226,083,000 242,726,000 251,907,000 240,360,000 249,643,000 249,170,000 159,024,000 156,443,000 158,722,000 146,512,000 140,821,000 137,590,000 142,298,000  
        intangible assets, net of accumulated amortization of 2,138 and 1,425 as of september 30, 2025 and december 31, 2024, respectively
      		 7,362,000                   
        other non-current assets
      		 614,000 676,000 387,000 407,000 458,000 146,000 146,000 146,000 146,000 146,000 215,000 146,000 146,000 134,000 134,000     
        intangible assets, net of accumulated amortization of 1,900 and 1,425 as of june 30, 2025 and december 31, 2024, respectively
      		  7,600,000                  
        intangible assets, net of accumulated amortization of 1,663 and 1,425 as of march 31, 2025 and december 31, 2024, respectively
      		   7,837,000                 
        intangible assets, net of accumulated amortization of 1,425 and 475 as of december 31, 2024 and december 31, 2023, respectively
      		    8,075,000                
        intangible assets, net of accumulated amortization of 1,188 and 475 as of september 30, 2024 and december 31, 2023, respectively
      		     8,312,000               
        intangible assets, net of accumulated amortization of 950 and 475 as of june 30, 2024 and december 31, 2023, respectively
      		      8,550,000              
        intangible assets, net of accumulated amortization of 713 and 475 as of march 31, 2024 and december 31, 2023, respectively
      		       8,787,000             
        intangible assets, net of accumulated amortization of 475 and 0 as of december 31, 2023 and december 31, 2022, respectively
      		        9,025,000            
        intangible assets, net of accumulated amortization of 238 and 0 as of september 30, 2023 and december 31, 2022, respectively
      		         9,262,000           
        intangible assets
      		          9,500,000          
        operating lease and other liabilities
      		           1,058,000         
        operating lease liabilities
      		            339,000 330,000 383,000 435,000     
        derivative liability on term loan
      		               83,000 173,000 173,000 245,000 245,000 
        short-term debt
      		                    
        series a convertible preferred stock, 0.001 par value...
      		                    
        common stock class b, 0.001 par value...
      		                    
        liabilities, and stockholders’ equity
      		                    
        stockholders’ (deficit) equity
      		                    
        series a preferred stock, 0.001 par value...
      		                   7,935,000 
        common stock class a, 0.001 par value...
      		                   30,000 
        total stockholders’ (deficit) equity
      		                   -684,000 
        total liabilities, and stockholders’ equity
      		                   37,382,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                            
          cash flows from operating activities
        		                    
          net loss
        		-17,961,000 -16,288,000 -17,398,000 -15,922,000  -15,360,000    -17,521,000 -12,271,000 -13,454,000 -4,412,000 -12,133,000 -17,234,000 -9,036,000 -6,619,000 -6,418,000 -5,083,000 -2,432,000 
          adjustments to reconcile net loss to net cash from operating activities
        		                    
          depreciation and amortization expense
        		899,000 2,778,000 2,576,000 2,461,000 2,237,000 2,157,000 2,116,000 1,909,000 1,769,000 1,564,000 1,095,000 924,000 917,000 459,000 423,000 334,000 276,000 189,000 103,000 117,000 
          provision for allowance for credit losses
        		112,000 -69,000 81,000 500,000  174,000               
          share-based compensation expense
        		8,034,000 7,998,000 9,577,000 8,693,000 8,555,000 7,900,000 6,740,000 7,408,000 5,872,000 5,192,000 3,596,000 2,692,000 2,470,000 2,269,000 1,963,000 1,409,000 1,293,000 839,000 875,000 402,000 
          non-cash lease expense
        		571,000 556,000 555,000 578,000 1,742,000 -575,000 590,000 592,000 593,000 604,000 638,000 626,000 512,000 845,000 829,000 336,000     
          amortization of debt issuance costs
        		262,000 75,000 74,000 74,000 75,000 74,000 74,000 75,000 74,000 75,000 74,000 74,000 75,000 74,000 50,000 45,000 43,000 45,000 45,000 43,000 
          amortization of premium (discount) on marketable securities
        		5,000 -5,000 -37,000 -77,000                 
          other
        		587,000 531,000 32,000 187,000 358,000 21,000 69,000 90,000 41,000 159,000 -20,000 25,000 0        
          net changes in operating assets and liabilities, net of acquisitions
        		                    
          accounts receivable
        		11,685,000 -2,557,000 696,000 9,289,000 -17,192,000 1,208,000 2,476,000 7,821,000 -13,422,000 2,235,000 -1,907,000 3,793,000 -11,097,000 -2,054,000 -430,000 2,542,000 -6,973,000 -1,764,000 742,000 3,769,000 
          inventory
        		-335,000 973,000 -4,457,000 1,315,000 4,356,000 -2,332,000 -5,419,000 -6,615,000 67,000 -3,211,000 -3,515,000 -3,189,000 -2,742,000 -3,617,000 -1,862,000 -548,000 -378,000 -2,799,000 -389,000 478,000 
          prepaid expenses and other assets
        		608,000 -615,000 -1,285,000 1,369,000 1,348,000 653,000 1,680,000 -1,495,000 -182,000 613,000 -678,000 -963,000 390,000 -19,000 -2,272,000 1,233,000 751,000 -249,000 -2,540,000 -379,000 
          other non-current assets
        		-293,000 62,000 -289,000 -76,000 -18,000       -69,000 0 -12,000 0 -134,000     
          operating lease liabilities
        		-854,000 -829,000 -768,000 -785,000 -2,326,000 1,144,000 -634,000 -657,000    -478,000 -36,000 720,000 2,525,000 -133,000     
          accounts payable
        		6,811,000 -3,856,000 6,736,000 2,701,000 -8,127,000 576,000 -3,076,000 9,314,000 3,155,000 534,000 3,070,000 -3,592,000 787,000 4,782,000 -350,000 -607,000 1,614,000 -479,000 1,829,000 -1,173,000 
          accrued liabilities
        		-3,126,000 2,118,000 857,000 -6,166,000 4,850,000 -6,810,000 975,000 -6,918,000 9,482,000 1,183,000 939,000 -4,076,000 6,903,000 1,180,000 1,661,000 -2,619,000 5,873,000 1,337,000 567,000 -1,167,000 
          net cash from operating activities
        		7,240,000 -9,092,000 -3,050,000 4,198,000 -4,207,000 -11,842,000 -13,897,000 -7,221,000 532,000 -9,513,000 -8,335,000 -17,259,000 -5,358,000 -7,483,000 -10,566,000 -7,241,000 -3,752,000 -9,264,000 -3,731,000 -446,000 
          capital expenditures
        		-3,062,000 -2,809,000 -4,767,000 -3,543,000 -3,074,000 -2,863,000 -1,729,000 -3,927,000 -2,248,000 -3,501,000 -4,231,000 -1,478,000 -2,332,000 -5,857,000 -5,168,000 -1,481,000 -900,000 -939,000 -670,000 -196,000 
          free cash flows
        		4,178,000 -11,901,000 -7,817,000 655,000 -7,281,000 -14,705,000 -15,626,000 -11,148,000 -1,716,000 -13,014,000 -12,566,000 -18,737,000 -7,690,000 -13,340,000 -15,734,000 -8,722,000 -4,652,000 -10,203,000 -4,401,000 -642,000 
          cash flows from investing activities
        		                    
          purchases of available-for-sale marketable securities
        		-16,071,000 -4,640,000 -15,159,000 -15,090,000 -18,689,000 -24,179,000 0 -28,711,000 -29,790,000 -19,118,000 -21,407,000 -99,550,000         
          sales and maturities of available-for-sale marketable securities
        		11,317,000 16,185,000 16,669,000 16,739,000 25,184,000 32,805,000 24,162,000 36,396,000 37,045,000 27,216,000           
          purchases of property and equipment
        		-3,062,000 -2,809,000 -4,767,000 -3,543,000 -3,074,000 -2,863,000 -1,729,000 -3,927,000 -2,248,000 -3,501,000 -4,231,000 -1,478,000 -2,332,000 -5,857,000 -5,168,000 -1,481,000 -900,000 -939,000 -670,000 -196,000 
          net cash from investing activities
        		-7,816,000 8,736,000 -3,257,000 -1,894,000 3,421,000 5,763,000 22,433,000 3,758,000 5,007,000 4,597,000 -10,423,000 -80,480,000 -64,012,000 -5,857,000 -5,168,000 -1,481,000 -900,000 -939,000 -670,000 -196,000 
          cash flows from financing activities
        		                    
          debt issuance costs
        		-6,000                    
          payments on insurance premium financing
        		-466,000 -409,000                   
          proceeds from exercise of employee stock options
        		91,000 241,000 116,000 119,000 57,000 8,000 311,000 52,000 178,000 159,000 1,180,000 352,000 297,000 353,000 165,000 1,372,000 1,026,000 41,000 194,000 569,000 
          taxes from withheld shares
        		-207,000 -412,000 -14,000 -401,000 -31,000 0 0 -237,000             
          net cash from financing activities
        		-588,000 -10,000 987,000 -282,000 26,000 8,000 311,000 -185,000 165,000 159,000 1,180,000 107,879,000 297,000 353,000 18,784,000 1,372,000 1,026,000 41,000 107,804,000 -1,219,000 
          net increase in cash and cash equivalents
        		-1,164,000 -366,000 -5,320,000 2,022,000 -760,000 -6,071,000 8,847,000 -3,648,000    10,140,000 -69,073,000 -12,987,000   -3,626,000 -10,162,000   
          cash and cash equivalents at beginning of period
        		10,708,000 0 0 11,350,000 0 0 0 12,982,000 0 0 0 19,473,000 0 0 0 105,833,000 0 0 0 18,079,000 
          cash and cash equivalents at end of period
        		9,544,000 -366,000 -5,320,000 13,372,000 -760,000 -6,071,000 8,847,000 9,334,000 5,704,000 -4,757,000 -17,578,000 29,613,000 -69,073,000 -12,987,000 3,050,000 98,483,000 -3,626,000 -10,162,000 103,403,000 16,218,000 
          supplemental disclosure of cash flow information
        		                    
          cash paid for interest
        		858,000 1,259,000 1,266,000 1,229,000 1,223,000 1,242,000 1,173,000 1,317,000 1,304,000 1,296,000 1,282,000 1,285,000 1,311,000 1,190,000 946,000 951,000 983,000 0 972,000 1,945,000 
          noncash investing activities
        		                    
          unrealized losses, net on marketable securities
        		98,000 -33,000 7,000 40,000  -217,000               
          noncash financing activities
        		                    
          legal cost financing
        		497,000 524,000 183,000 45,000                 
          proceeds from insurance premium financing
        		 570,000                   
          operating lease right-of-use asset and lease liability adjustment due to lease incentive
        		    -80,000 2,000   0 -9,000 22,000 -35,000         
          unsettled matured marketable security and receivable from broker
        		      -100,000 2,100,000 -3,000,000            
          net income
        		       -18,676,000             
          adjustments to reconcile net income to net cash from operating activities
        		                    
          benefit from allowance for credit losses
        		                    
          gain on fair value adjustment to derivative liability
        		            0 0 -83,000 -90,000 0    
          debt extinguishment loss
        		            0 0       
          loss on impairment of long-lived assets
        		                    
          amortization (accretion) of premium (discount) on marketable securities
        		                    
          acquisition, net of cash acquired
        		        0 0           
          proceeds from interest bearing term debt
        		            0 0       
          proceeds from interest bearing revolving debt
        		            0 0       
          payments on interest bearing debt
        		                    
          proceeds from issuance of common stock from public offering, net of issuance costs and underwriting discount of 7.5 million
        		         0 0 107,527,000         
          operating lease right-of-use assets obtained in exchange for new lease liabilities
        		            0 0 0 15,300,000     
          unrealized (gains) losses, net on marketable securities
        		       94,000             
          noncash portion of internally developed software
        		                    
          accretion (amortization) of discount (premium) on marketable securities
        		     -233,000 -350,000 -335,000 -375,000 -368,000 -366,000 -297,000         
          unsettled marketable security purchase and payable to broker
        		                    
          benefit from allowance for doubtful accounts
        		       159,000             
          recovery of loss reserve for surgical instruments
        		           -23,000         
          payable to broker for unsettled marketable security purchases
        		           710,000         
          proceeds from issuance of common stock from public offering, net of issuance costs and underwriting discount of 7.5 million and 10.6 million
        		                    
          net changes in operating assets and liabilities, net of acquisitions:
        		                    
          other liabilities
        		        -616,000 -575,000           
          payments on ppp loan
        		                    
          net decrease in cash and cash equivalents
        		        5,704,000 -4,757,000      -7,350,000    -1,861,000 
          supplemental disclosure of cash flow information:
        		                    
          noncash investing activities:
        		                    
          unrealized (gains) losses on marketable securities
        		                    
          noncash financing activities:
        		                    
          issuance of common stock upon exercise of warrants
        		                0 0   
          conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock
        		                0 0   
          (recovery) provision for allowance for doubtful accounts
        		         1,000        16,000 5,000 -77,000 
          recovery of inventory obsolescence
        		               -3,000     
          repayment of term loan
        		             0       
          unrealized losses on marketable securities
        		         -71,000 163,000 29,000         
          provision for allowance for doubtful accounts
        		           38,000         
          net changes in operating assets and liabilities:
        		                    
          maturities of available-for-sale marketable securities
        		           20,548,000         
          impairment of capitalized surgical instruments
        		                    
          proceeds from ppp loan
        		                    
          proceeds from issuance of common stock upon initial public offering, net of issuance costs and underwriting fees of 10.6 million
        		                0 0   
          initial fair value of derivative liability
        		                    
          recovery for allowance for doubtful accounts
        		                    
          (recovery of) provision for inventory obsolescence
        		                    
          repayment of ppp loan
        		                    
          debt issuance costs paid to third parties
        		             0       
          supplemental disclosure of noncash financing activities:
        		                    
          (recovery) for allowance for doubtful accounts
        		                    
          (recovery) provision of inventory obsolescence
        		                    
          supplemental disclosure of noncash investing activities:
        		                    
          property and equipment received in exchange for lease liability
        		                    
          provision (recovery) for allowance for doubtful accounts
        		               30,000     
          unpaid offering costs included in accounts payable and accrued liabilities
        		                   1,118,000 
          provision for inventory obsolescence
        		                168,000 91,000   
          loss on early settlement of debt
        		                    
          proceeds from interest bearing debt
        		                    
          repayments on ppp loan
        		                    
          issuance of warrants for class a common stock in connection with the company’s credit facility
        		                    
          proceeds from sba loan
        		                    
          repayments on sba loan
        		                 0   
          (recovery) provision for inventory obsolescence
        		                   -27,000 
          repayment on sba loan
        		                   -1,788,000 
          non-cash financing activities: